12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

NanoCarrier, Orient Europharma deal

NanoCarrier and Orient signed a memorandum of understanding (MOU) to amend an October 2008 deal granting Orient rights to NanoCarrier's Nanoplatin. Under the MOU, NanoCarrier will grant...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >